Stay updated on Cabozantinib in RAI-Refractory DTC Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in RAI-Refractory DTC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-14T19:02:24.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T14:38:44.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has added a facility name and location details, along with specific medical terms related to differentiated thyroid carcinoma and cabozantinib, while removing various related topics and location descriptors.
    Difference
    2%
    Check dated 2025-08-31T11:45:40.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T01:55:34.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:14:20.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1.0%
    Check dated 2025-08-02T18:29:35.000Z thumbnail image

Stay in the know with updates to Cabozantinib in RAI-Refractory DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.